Research Topics
Genomes and Genes | John L CameronSummaryAffiliation: Johns Hopkins University Country: USA Publications
| Collaborators
|
Detail Information
Publications
One thousand consecutive pancreaticoduodenectomiesJohn L Cameron
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
Ann Surg 244:10-5. 2006..To trace the evolution of pancreaticoduodenectomy from the decade of the 1960s through the first decade of the new Millenium, through the experience of one surgeon doing 1000 consecutive operations...- Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreasMichael J Swartz
Department of Radiation Oncology and Molecular Radiation Sciences, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Hospital, Baltimore, MD 21231 2410, USA
Int J Radiat Oncol Biol Phys 76:839-44. 2010..Intraductal papillary mucinous neoplasms are mucin-producing cystic neoplasms of the pancreas. One-third are associated with invasive carcinoma. We examined the benefit of adjuvant chemoradiotherapy (CRT) for this cohort... 
Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysisMechteld C de Jong
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Ann Surg 252:142-8. 2010..To analyze the perioperative and long-term outcomes of patients undergoing liver-directed therapy after pancreaticoduodenectomy in a large dual-center cohort of patients...
Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expressionSteven R Hustinx
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
Cancer Biol Ther 3:1254-61. 2004..TAGmapper should prove to be a powerful tool for the discovery of novel tumor markers through assignment of uncharacterized SAGE tags...- Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancerMichael G House
Department of Surgery, the Indiana University School of Medicine, Indianapolis, USA
J Gastrointest Surg 10:138-45. 2006..Patterns of liver metastases from islet cell tumors, specifically multiple bilobar metastases that are not amenable to resection and/or ablation, predict a poor outcome despite resection of the primary pancreatic tumor... - Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasmsSteven R Hustinx
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
Cancer Biol Ther 4:596-601. 2005..4; 0.9-2.2, p = 0.14). Aberrant expression of 14-3-3sigma may contribute to the outcome of patients with pancreatic ductal adenocarcinoma... - MKK4 status predicts survival after resection of gastric adenocarcinomaSteven C Cunningham
Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21231-1000, USA
Arch Surg 141:1095-9; discussion 1100. 2006..This finding may provide a useful prognostic tool in patients with gastric adenocarcinoma... - Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyCharles C Hsu
Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, MD, USA
Ann Surg Oncol 17:981-90. 2010..Our goal was to examine efficacy of adjuvant CRT in resected pancreatic adenocarcinoma compared with surgery alone... - Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survivalTaylor S Riall
Departments of Surgery, The Sol Goldman Pancreas Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Gastrointest Surg 9:1191-204; discussion 1204-6. 2005..002)... - Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreasNorihiro Sato
Departments of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205-2196, USA
Am J Pathol 164:903-14. 2004..0001). Our findings suggest that preoperative assessment of gene expression profiles may be able to differentiate invasive from noninvasive IPMNs... - Gene expression profiling identifies markers of ampullary adenocarcinomaN Tjarda Van Heek
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205 2196, USA
Cancer Biol Ther 3:651-6. 2004..001). Measurement of markers of ampullary cancer such as osteopontin may aid in the early detection and differential diagnosis of patients with periampullary lesions... - Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratioBolanle Asiyanbola
Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Halsted 614, Baltimore, MD 22187 6681, USA
J Gastrointest Surg 13:752-9. 2009..There are limited data on patterns of recurrence and factors associated with local recurrence following pancreaticoduodenectomy for pancreatic adenocarcinoma and adjuvant 5-flurouracil-based chemoradiation therapy... - Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivorsTom C Nguyen
Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-4606, USA
J Gastrointest Surg 7:1-9; discussion 9-11. 2003..These results imply that no negative long-term QOL measures are associated with radical pancreaticoduodenectomy (as performed in this study) for periampullary adenocarcinoma... - Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitisJeffrey M Hardacre
Department of Surgery, The Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD 21287-4688, USA
Ann Surg 237:853-8; discussion 858-9. 2003..Nevertheless, differentiation from pancreatic neoplasia remains difficult. Patients undergoing pancreaticoduodenectomy for LPSP have durable relief of symptoms and a subjectively improved quality of life... - Intraductal papillary mucinous neoplasms of the pancreas: an updated experienceTaylor A Sohn
Departments of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Ann Surg 239:788-97; discussion 797-9. 2004..Based on the age at resection data, there appears to be a 5-year lag time from IPMN adenoma (63.2 years) to invasive cancer (68.1 years)... - Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysisMark B Slidell
Department of Surgery, Georgetown University Hospital, Washington, District of Columbia, USA
Ann Surg Oncol 15:165-74. 2008..LNR has never been investigated in a large population-based study of patients with pancreatic adenocarcinoma... - Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancerKieran Brune
Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
Am J Surg Pathol 30:1067-76. 2006..The multifocal nature of familial pancreatic neoplasia suggests that surveillance of these patients is warranted after partial pancreatectomy... - Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinomaMechteld C de Jong
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
J Surg Oncol 103:656-62. 2011..We sought to examine the association of size with outcomes following resection of pancreatic adenocarcinoma... - Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experienceLia Assumpcao
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
J Gastrointest Surg 12:1915-23. 2008..We sought to identify possible risk factors associated with chyle leaks following pancreatic resection, as well as determine the natural history of this rare complication... - Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinomaDavid P Horowitz
Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Int J Radiat Oncol Biol Phys 80:1391-7. 2011..To evaluate the efficacy of adjuvant chemoradiation therapy (CRT) for pancreatic adenocarcinoma patients ≥ 75 years of age... - Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factorsEric B Schneider
Department of Surgery and Center for Surgical Trials and Outcomes Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
J Am Coll Surg 214:390-8; discussion 398-9. 2012..The objective of the current study was to evaluate risk factors associated with readmission among a nationwide cohort of patients after colorectal surgery... - Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologiesChristine A Iacobuzio-Donahue
Departments of Pathology, Surgery, Oncology, and Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
Cancer Res 63:8614-22. 2003.... - Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancerCharles C Hsu
The Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 410 North Broadway Suite 1440, Baltimore, MD 21231 2410, USA
J Gastrointest Surg 16:753-61. 2012..This study examines the preoperative predictors of early mortality following PD and combines these variables into an early mortality risk score (EMRS)... - Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesionsAnil V Parwani
Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland 21231-2410, USA
Mod Pathol 16:299-308. 2003..It is noteworthy that all of these alterations occur at the level of carcinoma in situ... - Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional seriesSushanth Reddy
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
J Am Coll Surg 208:950-7; discussion 957-9. 2009..Solid-pseudopapillary neoplasms (SPNs) are rare pancreatic tumors with malignant potential. Clinicopathologic characteristics and outcomes of patients with SPN were reviewed... - Tumor size and location correlate with behavior of pancreatic serous cystic neoplasmsMouen A Khashab
Department of Medicine and Division of Gastroenterology and Hepatology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
Am J Gastroenterol 106:1521-6. 2011..Identification of factors associated with symptomatic or aggressive SCNs may aid management decisions. The aim of this study was to identify variables that predict aggressive SCNs... - Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreasBoris Hristov
Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD, USA
Int J Radiat Oncol Biol Phys 76:176-80. 2010..The purpose of this study was to compare outcomes between pancreaticoduodenectomy (PD) with and without mesenterico-portal vein resection (VR) in patients receiving adjuvant CRT for pancreatic adenocarcinoma... - Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experiencePeter J Kneuertz
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
J Gastrointest Surg 15:1917-27. 2011..We examined trends in the relative use of palliative bypass over time with an emphasis on identifying changes in surgical indications, type of bypass performed, as well as perioperative outcomes associated with surgical palliation... - p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitisChristophe Rosty
Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
Am J Surg Pathol 27:1495-501. 2003..This alteration, common to pancreatic cancer-associated PanINs, may contribute to the predisposition of patients with chronic pancreatitis to develop pancreatic ductal adenocarcinoma... - Predicting resectability of periampullary cancer with three-dimensional computed tomographyMichael G House
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
J Gastrointest Surg 8:280-8. 2004.... - Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institutionSteven C Cunningham
Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231-1000, USA
J Gastrointest Surg 9:718-25. 2005..Many of the reported differences among Western series may be due to cohort differences, such as stage of disease, extent of resection, tumor type, and tumor location... - Gallbladder cancer: the role of laparoscopy and radical resectionSamuel P Shih
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Ann Surg 245:893-901. 2007..We assess how laparoscopy has altered the presentation of patients with gallbladder cancer and determine whether radical resection in patients with gallbladder cancer is beneficial... - Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patientsK Ranh Voong
Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Hospital, Baltimore, MD 21231 6681, USA
Hum Pathol 41:113-22. 2010..Treatment with adjuvant chemoradiation therapy is associated with improved survival. The proportion of squamous differentiation in resected pancreatic adenosquamous carcinoma specimens does not appear to impact overall survival... - Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosisJordan M Winter
Department of Surgery, Johns Hopkins Medical Institutions, Halsted 610, 600 N Wolfe Street, Baltimore, MD 21287, USA
J Gastrointest Surg 14:379-87. 2010..We sought to examine the outcome of patients undergoing pancreaticoduodenectomy versus ampullectomy, as well as to identify factors predictive of lymph node metastasis in patients with ampullary neoplasms... - Risk factors for pancreatic leak after distal pancreatectomyHari Nathan
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Ann Surg 250:277-81. 2009..We sought to evaluate the incidence of and identify risk factors for the development of PL in patients undergoing distal pancreatectomy (DP) at a single high-volume institution... - Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survivalSushanth Reddy
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 22187, USA
Ann Surg 250:282-7. 2009..To analyze relative perioperative and long-term outcomes of patients undergoing total pancreatectomy versus pancreaticoduodenectomy... - Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intentSkye C Mayo
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Cancer 118:2674-81. 2012..Survival estimates, however, are dynamic and may change based on the time already survived. The authors sought to assess conditional survival among a large cohort of patients who underwent resection of PDAC... - Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-upTaylor S Riall
Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA
Surgery 140:764-72. 2006..Many studies have reported 5-year survival data after pancreaticoduodenectomy for periampullary adenocarcinoma. This study evaluates 10-year survival in patients surviving 5 years after initial surgery... - Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarraysNorihiro Sato
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205-2196, USA
Cancer Res 63:3735-42. 2003..Thus, a substantial number of genes are induced by 5Aza-dC treatment of pancreatic cancer cells, and many of them may represent novel targets for aberrant methylation in pancreatic carcinoma... - Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspectiveHari Nathan
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
J Surg Oncol 99:87-92. 2009..We sought to analyze peri-operative mortality and long-term survival following TP versus PP for pancreatic adenocarcinoma... - Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreasKristin J Redmond
Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Ann Surg Oncol 17:3112-9. 2010..This study was designed to examine the effect of adjuvant 5-FU-based chemoradiation therapy (CRT) after distal pancreatectomy for adenocarcinoma of the distal pancreas... - Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapySteven R Hustinx
Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
Cancer Biol Ther 4:83-6. 2005..Thus, pancreatic cancer is a promising cancer type in which to explore novel chemotherapeutic strategies to exploit the selective loss of MTAP function... - Pancreaticoduodenectomy in the very elderlyMartin A Makary
Department of Surgery, John Hopkins University School of Medicine and Bloomberg School of Public Health, Johns Hopkins Medical Institutions, 4940 Eastern Avenue, Baltimore, MD 21224, USA
J Gastrointest Surg 10:347-56. 2006..The advent of improved surgical outcomes and an aging population will likely result in a significant increase in the number of PDs performed in the next few decades... - Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyAmol K Narang
Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Radiat Oncol 6:126. 2011..We combined the experience of two institutions to better delineate which patients may benefit from adjuvant chemoradiation... - Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution studySusan Tsai
Department of Surgery, Johns Hopkins Medical Institutions, 600N Wolfe Street, Baltimore, MD 21287, USA
J Gastrointest Surg 14:1143-50. 2010..To examine the effect of body mass index (BMI) on clinicopathologic factors and long-term survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma... - Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planningHaoming Qiu
Department of Radiation Oncology and Molecular Radiation Sciences, Sol Goldman Pancreatic Cancer Research Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
Radiother Oncol 104:167-72. 2012.... - Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatmentGeorge A Poultsides
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Ann Surg Oncol 19:1928-35. 2012..Duodenal adenocarcinoma is a rare cancer usually studied as a group with periampullary or small bowel adenocarcinoma; therefore, its natural history is poorly understood... - Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring systemRaghunandan Venkat
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Arch Surg 146:1277-84. 2011..To develop and validate a risk score to predict the 30- and 90-day mortality after a pancreaticoduodenectomy or total pancreatectomy on the basis of preoperative risk factors in a high-volume program... - Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarraysChristine A Iacobuzio-Donahue
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA
Am J Pathol 162:1151-62. 2003..The genes and expressed sequence tags presented in this study provide clues to the pathobiology of pancreatic cancer and implicate a large number of potentially new molecular markers for the detection and treatment of pancreatic cancer... - Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosisJordan M Winter
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Ann Surg 243:673-80; discussion 680-3. 2006.... - Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literatureAkhil K Seth
Department of Surgery, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Carnegie 683, Baltimore, MD 21287, USA
J Gastrointest Surg 12:1061-7. 2008..Acinar cell carcinoma (ACC) is a rare, malignant neoplasm with a generally poor prognosis. We report our institutional series of 14 patients with ACC to determine current guidelines for their evaluation and treatment... - Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysisHari Nathan
Department of Surgery, The Johns Hopkins University School of Medicine, Room 442, Cancer Research Building, 1650 Orleans Street, Baltimore, MD 21231 1000, USA
J Gastrointest Surg 11:1488-96; discussion 1496-7. 2007..We suggest that these trends are largely caused by developments in imaging technology, improvements in patient selection, and advances in surgical techniques... - 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experienceJordan M Winter
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
J Gastrointest Surg 10:1199-210; discussion 1210-1. 2006..This is the largest single-institution experience with PD for pancreatic cancer. Patients who have cancers with favorable pathological features have a statistically significant improved long-term survival... - Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juiceNoriyoshi Fukushima
Department of' Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205-2196, USA
Cancer Biol Ther 2:78-83. 2003..methylated in pancreatic secretions, detection of methylated ppENK and pi6 in pure pancreatic juice obtained by direct cannulation of the pancreatic duct to avoid duodenal secretions may suggest the presence of pancreatic adenocarcinoma.. - Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patientsJason K Sicklick
Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
Ann Surg 241:786-92; discussion 793-5. 2005..Early referral to a tertiary care center with experienced hepatobiliary surgeons and skilled interventional radiologists would appear to be necessary to assure optimal results... - Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarrayAnirban Maitra
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
Mod Pathol 16:902-12. 2003.... - Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?Ana Luiza Gleisner
Department of Surgery, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 22187 6681, USA
Cancer 110:2484-92. 2007..Specifically, the role of hepatic resection for metastatic periampullary or pancreatic adenocarcinoma remains controversial... - Pancreatic resection of isolated metastases from nonpancreatic primary cancersSushanth Reddy
Department of Surgery, The Johns Hopkins University, 600 North Wolfe Street, Carnegie 681, Baltimore, Maryland 21287, USA
Ann Surg Oncol 15:3199-206. 2008..The goal of this study is to report the safety and efficacy of pancreatic resection for isolated metastatic cancers from nonpancreatic primary disease... - Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tagsDengfeng Cao
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA
Cancer Biol Ther 3:1081-9; discussion 1090-1. 2004.... - Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortalityCharles J Yeo
Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
Ann Surg 236:355-66; discussion 366-8. 2002..To evaluate, in a prospective, randomized single-institution trial, the end points of operative morbidity, operative mortality, and survival in patients undergoing standard versus radical (extended) pancreaticoduodenectomy... - Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarraysSharon L Swierczynski
Department of Pathology, The Johns Hopkinds University School of Medicine, Baltimore, MD 21231, USA
Hum Pathol 35:357-66. 2004..Therefore, these markers are potentially useful in developing diagnostic tests and treatment paradigms for tumors involving the biliary system... - Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinomaPeter Peng
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
J Gastrointest Surg 16:1478-86. 2012..Sarcopenia--the measurement of muscle wasting--may be a more objective and comprehensive patient-specific factor associated with long-term survival... - Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreasGeorge A Poultsides
Department of Surgery, Sidney Kimmel Cancer Center, Johns Hopkins Hospital, Baltimore, MD, USA
Ann Surg 251:470-6. 2010....